Position in MRNA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$50,236,526
+$49,711,575 QoQ
Shares Held
988,908
+5455.4% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 44.45994976276863.ToString("F0")%
Shared 0.ToString("F0")%
None 55.54005023723138.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Mar 31, 2025CallValue
$82,215
CallShares
2,900
PutValue
$473,445
PutShares
16,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allianz Asset Management GmbH holds $654,142,197 across 68 Biotechnology names. MRNA ranks #3 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
301,196 | $232,716,076 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
610,297 | $115,376,647 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
988,908 | $50,236,526 | |
| 4 | EXEL |
Exelixis, Inc.
|
954,551 | $40,940,690 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
400,020 | $22,597,128 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,441,683 | $20,846,736 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
47,662 | $15,769,925 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
706,664 | $15,730,340 |
All Filings in MRNA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,236,526 | 988,908 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $524,951 | 17,801 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $213,536 | 8,267 | Shares | Defined | 2025-11-04 | |
| 2025-03-31 | $1,545,414 | 54,512 | Shares | Defined | 2025-05-05 | |
| 2025-03-31 | $473,445 | 16,700 | Put | Defined | 2025-05-05 | |
| 2025-03-31 | $82,215 | 2,900 | Call | Defined | 2025-05-05 | |
| 2024-12-31 | $4,060,120 | 97,646 | Shares | Defined | 2025-02-03 | |
| 2024-12-31 | $694,386 | 16,700 | Put | Defined | 2025-02-03 | |
| 2024-12-31 | $120,582 | 2,900 | Call | Defined | 2025-02-03 | |
| 2024-09-30 | $6,354,263 | 95,081 | Shares | Defined | 2024-11-13 | |
| 2024-09-30 | $193,807 | 2,900 | Call | Defined | 2024-11-13 | |
| 2024-09-30 | $1,116,061 | 16,700 | Put | Defined | 2024-11-13 | |
| 2024-06-30 | $11,120,224 | 93,644 | Shares | Defined | 2024-08-13 | |
| 2024-06-30 | $724,375 | 6,100 | Call | Defined | 2024-08-13 | |
| 2024-06-30 | $2,612,500 | 22,000 | Put | Defined | 2024-08-13 | |
| 2024-03-31 | $31,968 | 300 | Put | Defined | 2024-05-14 | |
| 2024-03-31 | $9,099,477 | 85,393 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $10,945,167 | 110,057 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $28,665,762 | 277,527 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $39,314,361 | 323,575 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $59,236,879 | 385,707 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $54,142,315 | 301,427 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $32,640,192 | 276,027 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $119,042,045 | 833,336 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $140,289,402 | 814,405 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $387,915,016 | 1,007,938 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $463,891,169 | 1,974,173 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $342,087,362 | 2,612,351 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $27,708,472 | 265,229 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $25,016,563 | 353,591 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $21,628,944 | 336,847 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,578,728 | 319,824 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||